Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

INTRODUCTION: Regorafenib is an oral multikinase inhibitor for the treatment of metastatic colorectal cancer (mCRC). The clinical factors that may affect adherence to regorafenib remain unclear. The aim of this study was to evaluate adherence to regorafenib with mCRC and to identify factors that mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Kazuyoshi, Wakatsuki, Takeru, Soejima, Azusa, Kobayashi, Kazuo, Yokokawa, Takashi, Aoyama, Takeshi, Suzuki, Kenichi, Suenaga, Mitsukuni, Yamaguchi, Kensei, Inoue, Ayaka, Machida, Yoshiaki, Hama, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800560/
https://www.ncbi.nlm.nih.gov/pubmed/31686792
http://dx.doi.org/10.2147/PPA.S217835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800560/
https://www.ncbi.nlm.nih.gov/pubmed/31686792
http://dx.doi.org/10.2147/PPA.S217835

Ejemplares similares